Aldehyde dehydrogenase 2 as a therapeutic target in oxidative stress-related diseases: post-translational modifications deserve more attention

J Gao, Y Hao, X Piao, X Gu - International journal of molecular sciences, 2022 - mdpi.com
Aldehyde dehydrogenase 2 (ALDH2) has both dehydrogenase and esterase activity; its
dehydrogenase activity is closely related to the metabolism of aldehydes produced under …

Drug repurposing in cardiovascular inflammation: Successes, failures, and future opportunities

L Chaffey, A Roberti, DR Greaves - Frontiers in Pharmacology, 2022 - frontiersin.org
Drug repurposing is an attractive, pragmatic approach to drug discovery that has yielded
success across medical fields over the years. The use of existing medicines for novel …

Advantages and disadvantages of disulfiram coadministered with popular addictive substances

P Kleczkowska, D Sulejczak, M Zaremba - European Journal of …, 2021 - Elsevier
Disulfiram (DSF) is a well-known anti-alcohol agent that inhibits aldehyde dehydrogenase
and results in extreme 'hangover'symptoms when consumed with alcohol. This drug …

Brain microdialysis coupled to LC-MS/MS revealed that CVT-10216, a selective inhibitor of aldehyde dehydrogenase 2, alters the neurochemical and behavioral …

S Kim, EY Jang, SH Song, JS Kim, IS Ryu… - ACS Chemical …, 2021 - ACS Publications
Methamphetamine (MA), a potent central nervous system stimulant, mainly affects the brain
dopaminergic and serotoninergic systems. Monoamine oxidase, catechol-O …

A new use for old drugs: identifying compounds with an anti-obesity effect using a high through-put semi-automated Caenorhabditis elegans screening platform

F Haerkens, C Kikken, L Kirkels, M van Amstel… - Heliyon, 2022 - cell.com
Obesity is one of the most common global health problems for all age groups with obese
people at risk of a variety of associated health complications. Consequently, there is a need …

Disulfiram: A novel repurposed drug for cancer therapy

M Zeng, B Wu, W Wei, Z Jiang, P Li… - Chinese Medical …, 2024 - journals.lww.com
Cancer is a major global health issue. Effective therapeutic strategies can prolong patients'
survival and reduce the costs of treatment. Drug repurposing, which identifies new …

Clinical, pharmacological, and formulation evaluation of disulfiram in the treatment of glioblastoma-a systematic literature review

BM Benkő, DA Lamprou, A Sebestyén… - Expert Opinion on …, 2023 - Taylor & Francis
Introduction Glioblastoma (GB) is one of the most challenging central nervous system (CNS)
tumors in treatment options and response, urging the development of novel management …

Disulfiram Exerts Antiadipogenic, Anti-Inflammatory, and Antifibrotic Therapeutic Effects in an In Vitro Model of Graves' Orbitopathy

X Wang, S Yang, H Ye, J Chen, L Shi, L Feng, X Wang… - Thyroid, 2022 - liebertpub.com
Background: Adipogenesis, glycosaminoglycan hyaluronan (HA) production, inflammation,
and fibrosis are the main pathogenic mechanisms responsible for Graves' orbitopathy (GO) …

Drug repurposing for metabolic disorders: Scientific, technological and economic issues

NL Bui, DA Hoang, QA Ho, TNN Thi, V Singh… - Progress in Molecular …, 2024 - Elsevier
Obesity, diabetes, and other metabolic disorders place a huge burden on both the physical
health and financial well-being of the community. While the need for effective treatment of …

Risk of non-hypoglycemic agents for hypoglycemia-related hospitalization in patients with type 2 diabetes: A large-scale medical receipt database analysis

T Horii, M Otsuka, T Yasu - BMJ Open Diabetes Research and Care, 2023 - drc.bmj.com
Introduction Hypoglycemia is listed as an adverse effect in the package inserts of not only
hypoglycemic agents but also many other drugs. We aimed to clarify real-world factors …